USFDA classifies Jubilant HollisterStier Spokane facility as VAI
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-09-10 11:30 GMT | Update On 2024-09-10 11:30 GMT
Noida: Jubilant Pharmova Limited has announced that Jubilant HollisterStier LLC (JHS) has received a communication from the USFDA, through which the regulatory agency intimated that pursuant to its audit of JHS’s contract manufacturing facility located at Spokane, Washington (USA) from May 28,2024 to June 6, 2024, it has determined the inspection classification of the facility as “Voluntary Action indicated”.
Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of the company.
It is a leading integrated contract manufacturer of sterile injectables (both liquid and lyophilization), ampoules and ophthalmics (Ointment, liquid and creams). With facilities in North America, Jubilant HollisterStier provides specialized manufacturing for the pharmaceutical and biopharmaceutical industries. The services include a full-range of support to streamline the manufacturing processes, from process qualifications through commercial release.
Read also:Jubilant Pharmova reports significant increase in Q1 net profit to Rs 481.8 crore
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.